Back to results
US 5,434,188 AGranted
1-ether and 1-thioether-naphthalene-2-carboxamides as inhibitors of cell adhesion and as inhibitors of the activation of HIV
AssigneeWarner-Lambert Company
InventorsDiane H. Boschelli, David T. Connor, Sony S. Khatana, James B. Kramer, Paul C. Unangst
Life of this patent
Estimating the term…
Abstract
1-Ether and 1-thioether-naphthalene-2-carboxamides are described, methods of manufacture therefor and their use as agents which inhibit leukocyte adherence to vascular endothelium and, as such, are effective therapeutic agents for treating inflammatory diseases, and their utility in inhibiting the activation of human immunodeficiency virus (HIV), latent in infected humans.
Claims11
A compound of the formula ##STR4## wherein R.sub.1 is lower alkyl, phenyl or benzyl;
- R.sub.2 is hydrogen or lower alkyl;
- X is O;
- and
- R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are each independently hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy, phenoxy, benzyloxy, nitro, or --NR.sub.7 R.sub.8 in which R.sub.7 and R.sub.8 are each independently hydrogen or lower alkyl, or a pharmaceutically acceptable acid addition salt thereof;
- with the proviso that either R.sub.4 or R.sub.5 must be lower alkoxy.
2 more elements
Dependencies are inferred from the claim text.